Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close

News & Events

Tillotts Pharma AG signs POTELLIGENT<sup>®</sup> CHOK1SV<sup>TM</sup> Cell Line Technology Licensing Agreement with Lonza and BioWa

Press Release

Tillotts Pharma AG signs POTELLIGENT® CHOK1SVTM Cell Line Technology Licensing Agreement with Lonza and BioWa

• Tillotts Pharma AG will use the POTELLIGENT® CHOK1SV™ Cell Line, developed by Lonza[...] Read more »
Employee opening event of new, modern office

News

Employee opening event of new, modern office

Following the inauguration of the new office space in Salmenpark on March 5th, Tillotts Ph[...] Read more »
Tillotts Pharma AG opens new, state-of-the-art office in Rheinfelden, Switzerland

Press Release

Tillotts Pharma AG opens new, state-of-the-art office in Rheinfelden, Switzerland

PRESS RELEASE RHEINFELDEN, Switzerland, March 5th, 2018 Tillotts Pharma AG (Tillotts[...] Read more »
Tillotts Pharma announces MHRA<sup>1</sup> approval of Entocort<sup>TM</sup> Capsules for Microscopic Colitis

Press Release

Tillotts Pharma announces MHRA1 approval of EntocortTM Capsules for Microscopic Colitis

PRESS RELEASE RHEINFELDEN, Switzerland, February 5th 2018 – Tillotts Pharma AG (“T[...] Read more »
Today, we define where we want to be tomorrow

News

Today, we define where we want to be tomorrow

Rapid growth and an increased number of employees meant that the Tillotts Pharma AG (Tillo[...] Read more »
Tillotts Pharma AG signs license agreement on antibody technology with Inven2

Press Release

Tillotts Pharma AG signs license agreement on antibody technology with Inven2

RHEINFELDEN, Switzerland, January 22, 2018 Inven2 AS (Inven2), a technology transfer an[...] Read more »
1 9 10 11 12 13 22